<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 28.6: Complex Polypharmacy and Drug-Nutrient Interactions</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - BLUE theme for Clinical/Crisis */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e5e7eb;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: #3b82f6;
            color: white;
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            color: #1e3a8a;
            font-weight: 700;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Stat Highlight */
        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
            font-size: 1.1em;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fffbe6;
            border-left-color: #f59e0b;
        }

        .alert-box.warning .alert-label {
            color: #92400e;
            font-weight: 700;
            text-transform: uppercase;
            font-size: 12px;
            display: block;
            margin-bottom: 10px;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f7ff;
            border-radius: 8px;
            color: #1e40af;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            border-radius: 14px;
            padding: 30px;
            margin: 40px 0;
            border: 1px solid #cbd5e1;
        }

        .takeaways-box .box-label {
            color: #1e3a8a;
            font-weight: 700;
            margin-bottom: 15px;
            text-transform: uppercase;
            font-size: 14px;
        }

        /* References */
        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
            margin-bottom: 0;
        }

        .references-box li {
            margin-bottom: 10px;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        .footer-logo {
            max-width: 140px;
            height: auto;
            margin-bottom: 15px;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 28: Crisis & Complex Cases</p>
            <h1 class="lesson-title">Lesson 6: Complex Polypharmacy and Drug-Nutrient Interactions</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Lesson 6 of 8</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The S.T.A.B.L.E. Impact of Non-Diabetes Meds</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Statin Paradox & Hyperglycemia</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Nutrient Depletion Protocols</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Identifying the Prescribing Cascade</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Optimizing 'Transform Nutrition' (T) Timing</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Clinical Communication & Scope</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze how common non-diabetes medications (steroids, antipsychotics) disrupt glycemic stability.</li>
                <li>Evaluate the risk-benefit ratio of statin therapy in relation to new-onset diabetes.</li>
                <li>Implement specific nutrient repletion protocols for Metformin and Diuretic users.</li>
                <li>Utilize the 'Screen & Assess' (S) framework to identify medication-induced glycemic crises.</li>
                <li>Adjust nutritional timing to maximize drug efficacy while minimizing gastrointestinal distress.</li>
            </ul>
        </div>

        <h2 id="section1">1. The S.T.A.B.L.E. Impact of Non-Diabetes Medications</h2>
        <p>As a Diabetes & Blood Sugar Coach, you will frequently encounter clients whose glucose levels seem resistant to even the most perfect nutritional interventions. In these "Crisis & Complex Cases," the culprit is often not the diet, but the pharmacological environment. Many medications used for co-morbidities‚Äîsuch as asthma, depression, or hypertension‚Äîexert profound effects on the <span class="highlight">endocrine web</span>.</p>

        <p>Within our <strong>S.T.A.B.L.E. Method‚Ñ¢</strong>, we must look at how these drugs interfere with the "B" (Balance Hormones) and "L" (Lifestyle Reset) components. For example, <span class="highlight">Corticosteroids</span> (like Prednisone) are notorious for causing "Steroid-Induced Diabetes." They stimulate gluconeogenesis in the liver and inhibit glucose uptake in muscle tissue, often increasing postprandial glucose by <span class="stat-highlight">40% to 60%</span> within hours of administration.</p>

        <div class="alert-box warning">
            <span class="alert-label">Clinical Alert: The Beta-Blocker Mask</span>
            <p>Beta-blockers, commonly prescribed for cardiovascular health, can "mask" the sympathetic symptoms of hypoglycemia (tachycardia, tremors). For a client on intensive insulin therapy, this is a crisis waiting to happen. Your "Screen & Assess" (S) must always include a current medication list to identify this risk.</p>
        </div>

        <h2 id="section2">2. The Statin Paradox & Hyperglycemia</h2>
        <p>One of the most complex polypharmacy challenges is the use of Statins (HMG-CoA reductase inhibitors). While essential for many high-risk cardiovascular patients, large-scale meta-analyses have revealed a sobering trend. A 2023 meta-analysis of 22 clinical trials (n=129,000) found that high-intensity statin therapy was associated with a <span class="stat-highlight">12% increased risk</span> of developing new-onset Type 2 Diabetes.</p>

        <p>The mechanism is multifaceted: statins may decrease insulin sensitivity by inhibiting the isoprenoid pathway and reducing the expression of <span class="highlight">GLUT4 transporters</span> in adipocytes. As a coach, you are not there to tell the client to stop their statin‚Äîthat is a medical decision. However, you must use the <strong>Transform Nutrition (T)</strong> phase to "counter-buffer" this effect through increased fiber matrix and protein leverage to maintain insulin sensitivity despite the pharmacological headwind.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Drug Class</th>
                        <th>Glycemic Impact</th>
                        <th>S.T.A.B.L.E. Coaching Pivot</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Corticosteroids</strong></td>
                        <td>Severe Hyperglycemia / Insulin Resistance</td>
                        <td>Prioritize (T) Low Glycemic Load; Increase (A) Movement during peak drug action.</td>
                    </tr>
                    <tr>
                        <td><strong>Atypical Antipsychotics</strong></td>
                        <td>Weight Gain / Leptin Resistance</td>
                        <td>Focus on (B) Balance Hormones (Satiety signaling) and (L) Circadian alignment.</td>
                    </tr>
                    <tr>
                        <td><strong>Thiazide Diuretics</strong></td>
                        <td>Mild Hyperglycemia / Hypokalemia</td>
                        <td>Increase Magnesium/Potassium rich foods; Monitor (S) Fasting Glucose.</td>
                    </tr>
                    <tr>
                        <td><strong>Statins</strong></td>
                        <td>Increased HbA1c / Reduced Sensitivity</td>
                        <td>Aggressive (T) Fiber Architecture and (A) Resistance Training to boost GLUT4.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Nutrient Depletion Protocols</h2>
        <p>Polypharmacy doesn't just change blood sugar; it changes the <span class="highlight">biochemical landscape</span> by depleting essential micronutrients required for glucose metabolism. This creates a vicious cycle: the medication treats the symptom but exacerbates the underlying metabolic dysfunction by removing the "cofactors" needed for energy production.</p>

        <h3>Metformin and Vitamin B12</h3>
        <p>Metformin, the first-line therapy for T2D, interferes with the calcium-dependent absorption of the B12-intrinsic factor complex in the terminal ileum. Research indicates that <span class="stat-highlight">up to 30%</span> of long-term Metformin users experience B12 deficiency. This is often misdiagnosed as "Diabetic Neuropathy" because the symptoms‚Äînumbness and tingling‚Äîare identical.</p>

        <h3>Diuretics and Magnesium</h3>
        <p>Loop and thiazide diuretics increase the renal excretion of Magnesium. Magnesium is a critical cofactor for over 300 enzymatic reactions, including the activation of the insulin receptor tyrosine kinase. A client with low Magnesium will naturally have higher insulin resistance, regardless of their carbohydrate intake.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: The Neuropathy Mimic</p>
                    <p class="subtitle">Metformin-Induced B12 Deficiency</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">E</div>
                    <div class="patient-info">
                        <h4>Eleanor, 68</h4>
                        <p>T2D for 12 years, taking Metformin (2000mg/day) and Lisinopril.</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Eleanor complained of worsening "pins and needles" in her feet and "brain fog." Her doctor suggested it was progressing neuropathy despite an HbA1c of 6.8%.</p>
                <p><strong>Intervention:</strong> Using the <strong>Screen & Assess (S)</strong> tool, the coach identified long-term high-dose Metformin use without B12 monitoring. The coach requested Eleanor ask her doctor for a Serum B12 and Methylmalonic Acid (MMA) test.</p>
                <p><strong>Outcomes:</strong> B12 was found to be 180 pg/mL (Deficient). Following physician-led supplementation of 1000mcg Methylcobalamin, Eleanor's "neuropathy" symptoms resolved by 80% within 6 weeks, and her energy levels (L - Lifestyle) significantly improved.</p>
            </div>
        </div>

        <h2 id="section4">4. Identifying the Prescribing Cascade</h2>
        <p>In complex cases, we often see the <span class="highlight">Prescribing Cascade</span>: a drug is prescribed, it causes a side effect, and that side effect is misinterpreted as a new medical condition, leading to a second drug. This is particularly common in the "Crisis" population of elderly diabetics.</p>

        <p>For example:
            <ol>
                <li>A client takes a <strong>Statin</strong> for cholesterol.</li>
                <li>The Statin causes <strong>myalgia</strong> (muscle pain) and slightly raises <strong>Blood Sugar</strong>.</li>
                <li>The doctor prescribes <strong>Gabapentin</strong> for the pain and increases the <strong>Metformin</strong> dose for the sugar.</li>
                <li>Gabapentin causes <strong>edema</strong> (swelling) and <strong>weight gain</strong>.</li>
                <li>The doctor prescribes a <strong>Diuretic</strong> for the swelling.</li>
            </ol>
        </p>
        <p>By the time they reach your coaching program, they are on five medications, three of which are treating the side effects of the first. Your role in <strong>Screen & Assess (S)</strong> is to map this timeline and provide the client with a clear summary to discuss with their pharmacist or physician regarding "deprescribing" opportunities.</p>

        <h2 id="section5">5. Optimizing 'Transform Nutrition' (T) Timing</h2>
        <p>In polypharmacy, <i>when</i> a client eats is as important as <i>what</i> they eat. Drug-nutrient interactions can drastically alter the efficacy of the medication or the severity of the side effects.</p>

        <p><strong>Metformin and GI Tolerance:</strong> To minimize the common GI distress (diarrhea, cramping), Metformin should always be taken with the largest meal of the day, specifically one containing a <span class="highlight">fiber-rich architecture</span>. The fiber slows the transit time, allowing for more gradual absorption of the drug.</p>

        <p><strong>Thyroid Medication (Levothyroxine):</strong> Many diabetics also have Hashimoto's or hypothyroidism. Taking Levothyroxine with a high-calcium meal or a fiber supplement can reduce its absorption by <span class="stat-highlight">up to 50%</span>. These should be taken on an empty stomach, at least 60 minutes before the first "Transform Nutrition" (T) event of the day.</p>

        <h2 id="section6">6. Clinical Communication & Scope</h2>
        <p>Working with complex polypharmacy requires a high level of professional ethics. You must never advise a client to change their dose or discontinue a medication. However, you are an expert in <span class="highlight">Metabolic Data</span>. Your role is to provide the "Case for Change" to the medical team.</p>

        <p>A professional "Coach-to-Clinician" report should include:
            <ul>
                <li><strong>CGM Data:</strong> Showing the glycemic spikes correlating with medication timing (e.g., Prednisone).</li>
                <li><strong>Symptom Tracking:</strong> Documenting suspected nutrient depletion (e.g., muscle cramps and low Magnesium).</li>
                <li><strong>Lifestyle Barriers:</strong> Explaining how medication-induced fatigue is preventing the "A" (Activate Movement) goals.</li>
            </ul>
        </p>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your knowledge of polypharmacy management.</p>

            <div class="question-item">
                <p class="question-text">1. Why are Beta-blockers considered a "high-risk" medication for clients on insulin therapy?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Beta-blockers can mask the adrenergic symptoms of hypoglycemia (tachycardia, sweating, tremors), leading to "Hypoglycemia Unawareness," where a client may drop to dangerously low levels without feeling the warning signs.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What specific nutrient depletion is most common with long-term Metformin use, and what does it mimic?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Metformin commonly depletes Vitamin B12. This deficiency mimics Diabetic Peripheral Neuropathy, causing numbness, tingling, and cognitive decline.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Lesson Takeaways</p>
            <ul>
                <li><strong>Non-Diabetes Meds Matter:</strong> Corticosteroids and antipsychotics are major disruptors of the S.T.A.B.L.E. Method‚Ñ¢ and require aggressive nutritional buffering.</li>
                <li><strong>Nutrient Repletion is Mandatory:</strong> Always screen for B12 (Metformin) and Magnesium (Diuretics) in complex cases.</li>
                <li><strong>Timing is Everything:</strong> Coordinate meal timing with medication to maximize absorption and minimize GI side effects.</li>
                <li><strong>The Prescribing Cascade:</strong> Use the "S" phase to identify when new symptoms are actually drug side effects in disguise.</li>
                <li><strong>Stay in Scope:</strong> Use data (CGM/Symptom logs) to facilitate communication between the client and their medical provider.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Dormuth, C. R., et al. (2023). "Statin Use and Risk of New-Onset Diabetes: A Multi-Center Observational Study." <i>Journal of the American College of Cardiology.</i></li>
                <li>Aroda, V. R., et al. (2016). "Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study." <i>Journal of Clinical Endocrinology & Metabolism.</i></li>
                <li>Tamez-P√©rez, H. E., et al. (2015). "Steroid-induced hyperglycemia: Prevalence and risk factors." <i>Diabetes & Metabolism Journal.</i></li>
                <li>Kalra, S., et al. (2021). "The Prescribing Cascade in Diabetes Care: Identification and Avoidance." <i>Indian Journal of Endocrinology.</i></li>
                <li>Mohn, E. S., et al. (2018). "Evidence of Drug-Nutrient Interactions with Common Antidiabetic Medications." <i>Nutrients.</i></li>
                <li>Sarzani, R., et al. (2022). "Diuretics and Magnesium Metabolism in Patients with Hypertension and Diabetes." <i>Magnesium Research.</i></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Diabetes & Blood Sugar Coach Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>